A clinical trial of an investigational, non-invasive medical device has shown that trans-spinal direct-current stimulation and peripheral nerve direct-current stimulation significantly reduced upper-limb spasticity in participants who had experienced a stroke. The treatment involves passing a direct electrical current across the spinal cord with a skin-surface electrode, known as trans-spinal direct-current stimulation (tsDCS), and adding […]
PathMaker Neurosystems Inc.
NIH inks $5m partnership with PathMaker Neurosystems for MyoRegulator spasticity device
PathMaker Neurosystems said today it signed a $5 million cooperative partnership deal with the National Institutes of Health to support continued development of its MyoRegulator neurostimulation system designed to treat spasticity secondary to stroke. The MyoRegulator device, based on PathMaker’s DoubleStim technology, is designed to provide simultaneous, non-invasive stimulation at spinal and peripheral locations, the Boston and Paris-based […]
PathMaker Neurosystems wins BpiFrance grant to support MyoRegulator clinical dev
PathMaker Neurosystems said today that it won a grant from BpiFrance to support the company’s MyoRegulator neuromodulation device designed to treat patients with neuromotor spasticity. The MyoRegulator device, based on PathMaker’s DoubleStim technology, is designed to provide simultaneous, non-invasive stimulation at spinal and peripheral locations, the Boston and Paris-based company said. The grant will support the initiation of […]
PathMaker NeuroSystems inks MyoRegulator trial with France’s Brain & Spine Institute
PathMaker Neurosystems said today it will work with France’s Brain and Spine Institute to launch a human clinical trail of its MyoRegulator neromodulation system designed to treat patients with neuromotor spasticity. The MyoRegulator device, based on PathMaker’s DoubleStim technology, is designed to provide simultaneous, non-invasive stimulation at spinal and peripheral locations, the Boston-based company said. “We are very […]
PathMaker and Feinstein Inst launch MyoRegulator spasticity trial
PathMaker Neurosystems said today it paired with the Feinstein Institute and Northwell Health to launch an IRB-approved clinical trial of its MyoRegulator device designed to treat muscle spasticity. The MyoRegulator device, based on PathMaker’s DoubleStim technology, is designed to provide simultaneous, non-invasive stimulation at spinal and peripheral locations, the Boston-based company said. “Initiating our company’s 1st formal […]
Ex-Insulet chief DeSisto out before he’s in at MannKind | Personnel Moves
MannKind Corporation said today it withdrew an offer that would have made ex-Insulet (NSDQ:PODD) CEO Duane DeSisto its new CEO only 19 days after officially posting its offer to DeSisto. The offer was withdrawn as objections were raised by DeSisto’s former employer Insulet, who said the new position would violate its non-competition agreement, which will be […]
PathMaker Neurosystems wins the fast track at FDA for MyoRegulator device
PathMaker Neurosystems said it won expedited access pathway designation from the FDA for its MyoRegulator PM-2200 system, which is designed to treat muscle spasticity. The MyoRegulator device, based on PathMaker’s DoubleStim technology, is designed to provide simultaneous, non-invasive stimulation at spinal and peripheral locations, the Boston-based company said. In June PathMaker inked a deal with Proven Process […]
Proven Process, PathMaker Neurosystems ink deal for neurostim device
Proven Process said today that it’s partnering with PathMaker Neurosystems, a clinical-stage neuromodulation company, to develop and manufacture a device for treating patients with muscle tone disorders using trans-spinal direct current stimulation. Trans-spinal direct current stimulation is a novel form of non-invasive neurostim, Mansfield, Mass.-based Proven Process said. The spinal stimulation uses a direct current to stimulate […]